Is there immune surveillance against chronic myeloid leukaemia? Possibly, but not much

被引：22

作者：

Gale, Robert Peter ^{[1
]}

Opelz, Gerhard ^{[2
]}

机构：

[1] Imperial Coll London, Div Expt Med, Dept Med, Haematol Res Ctr, London, England

[2] Heidelberg Univ, Dept Transplantat Immunol, Inst Immunol, Heidelberg, Germany

来源：

LEUKEMIA RESEARCH | 2017年 / 57卷

关键词：

MINIMAL RESIDUAL DISEASE; ORGAN-TRANSPLANTATION; CANCER INCIDENCE; REMISSION; IMATINIB;

D O I：

10.1016/j.leukres.2017.03.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：109 / 111

页数：3

共 15 条

[1] Cancer risk following organ transplantation:: a nationwide cohort study in Sweden [J].

Adami, J ;

Gäbel, H ;

Lindelöf, B ;

Ekström, K ;

Rydh, B ;

Glimelius, B ;

Ekbom, A ;

Adami, HO ;

Granath, F .

BRITISH JOURNAL OF CANCER, 2003, 89 (07) :1221-1227

[2] The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease [J].

Bose, S ;

Deininger, M ;

Gora-Tybor, J ;

Goldman, JM ;

Melo, JV .

BLOOD, 1998, 92 (09) :3362-3367

[3] Cancer immunoediting: from immunosurveillance to tumor escape [J].

Dunn, GP ;

Bruce, AT ;

Ikeda, H ;

Old, LJ ;

Schreiber, RD .

NATURE IMMUNOLOGY, 2002, 3 (11) :991-998

[4] Is there really a specific graft-versus-leukaemia effect? [J].

Gale, R. P. ;

Fuchs, E. J. .

BONE MARROW TRANSPLANTATION, 2016, 51 (11) :1413-1415

[5] Commentary: does immune suppression increase risk of developing acute myeloid leukemia? [J].

Gale, R. P. ;

Opelz, G. .

LEUKEMIA, 2012, 26 (03) :422-423

[6]

HOROWITZ MM, 1990, BLOOD, V75, P555

[7] The Incidence of Leukemia, Lymphoma and Multiple Myeloma among Atomic Bomb Survivors: 1950-2001 [J].

Hsu, Wan-Ling ;

Preston, Dale L. ;

Soda, Midori ;

Sugiyama, Hiromi ;

Funamoto, Sachiyo ;

Kodama, Kazunori ;

Kimura, Akiro ;

Kamada, Nanao ;

Dohy, Hiroo ;

Tomonaga, Masao ;

Iwanaga, Masako ;

Miyazaki, Yasushi ;

Cullings, Harry M. ;

Suyama, Akihiko ;

Ozasa, Kotaro ;

Shore, Roy E. ;

Mabuchi, Kiyohiko .

RADIATION RESEARCH, 2013, 179 (03) :361-382

[8] Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial [J].

Mahon, Francois-Xavier ;

Rea, Delphine ;

Guilhot, Joelle ;

Guilhot, Francois ;

Huguet, Francoise ;

Nicolini, Franck ;

Legros, Laurence ;

Charbonnier, Aude ;

Guerci, Agnes ;

Varet, Bruno ;

Etienne, Gabriel ;

Reiffers, Josy ;

Rousselot, Philippe .

LANCET ONCOLOGY, 2010, 11 (11) :1029-1035

[9] Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation [J].

Offman, J ;

Opelz, G ;

Doehler, B ;

Cummins, D ;

Halil, O ;

Banner, NR ;

Burke, MM ;

Sullivan, D ;

Macpherson, P ;

Karran, P .

BLOOD, 2004, 104 (03) :822-828

[10]

Perl AE, 2013, J CLIN ONCOL, V31

← 1 2 →